Change In Working Capital - Abbvie Inc (NYSE:ABBV) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 162.35 USD -2.95%

Updated:

Abbvie Inc
Change in Working Capital

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Abbvie Inc
Change in Working Capital Peer Comparison

GILD

AMGN

MRNA

VRTX

REGN

Company		Change in Working Capital	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Abbvie Inc NYSE:ABBV	Change in Working Capital $2.8B	CAGR 3-Years 198%	CAGR 5-Years N/A	CAGR 10-Years 16%
	Gilead Sciences Inc NASDAQ:GILD	Change in Working Capital -$2.3B	CAGR 3-Years -12%	CAGR 5-Years -20%	CAGR 10-Years -15%
	Amgen Inc NASDAQ:AMGN	Change in Working Capital -$484m	CAGR 3-Years -31%	CAGR 5-Years N/A	CAGR 10-Years -2%
	Moderna Inc NASDAQ:MRNA	Change in Working Capital -$139m	CAGR 3-Years N/A	CAGR 5-Years -26%	CAGR 10-Years N/A
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Change in Working Capital -$265.7m	CAGR 3-Years -70%	CAGR 5-Years N/A	CAGR 10-Years -48%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Change in Working Capital -$94.1m	CAGR 3-Years 60%	CAGR 5-Years 33%	CAGR 10-Years 7%

See Also

Based on the financial report for Dec 31, 2023, Abbvie Inc's Change in Working Capital amounts to 2.8B USD.

The average annual Change in Working Capital growth rates for Abbvie Inc have been 198% over the past three years , and 16% over the past ten years .

Join more than 131,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.